20 research outputs found

    COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity-A collaborative international study

    Get PDF
    Confinement during the COVID-19 pandemic is expected to have a serious and complex impact on the mental health of patients with an eating disorder (ED) and of patients with obesity. The present manuscript has the following aims: (1) to analyse the psychometric properties of the COVID Isolation Eating Scale (CIES), (2) to explore changes that occurred due to confinement in eating symptomatology; and (3) to explore the general acceptation of the use of telemedicine during confinement. The sample comprised 121 participants (87 ED patients and 34 patients with obesity) recruited from six different centres. Confirmatory Factor Analyses (CFA) tested the rational-theoretical structure of the CIES. Adequate goodness-of-fit was obtained for the confirmatory factor analysis, and Cronbach alpha values ranged from good to excellent. Regarding the effects of confinement, positive and negative impacts of the confinement depends of the eating disorder subtype. Patients with anorexia nervosa (AN) and with obesity endorsed a positive response to treatment during confinement, no significant changes were found in bulimia nervosa (BN) patients, whereas Other Specified Feeding or Eating Disorder (OSFED) patients endorsed an increase in eating symptomatology and in psychopathology. Furthermore, AN patients expressed the greatest dissatisfaction and accommodation difficulty with remote therapy when compared with the previously provided face-to-face therapy. The present study provides empirical evidence on the psychometric robustness of the CIES tool and shows that a negative confinement impact was associated with ED subtype, whereas OSFED patients showed the highest impairment in eating symptomatology and in psychopathology.This manuscript and research was supported by grants from the Ministeriode Economía y Competitividad (PSI2015-68701-R), Instituto de Salud Carlos III (ISCIII) (FIS PI14/00290/ INT19/00046nd PI17/01167) and co-funded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe. CIBERobn, CIBERsam and CIBERDEM are all initiatives of ISCIII. GMB is supported by a postdoctoral grant from FUNCIVA. This initiative is supported by Generalitat de Catalunya. LM is supported by a postdoctoral grant of the mexican institution Consejo Nacional de Ciencia y Tecnología (CONACYT). PPM was supported, in part, by a Portuguese Foundation for Science and Technology grant (POCI-01-0145-FEDER-028145). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript

    Marine mammals exploring the oceans pole to pole

    Get PDF
    Polar oceans are poorly monitored despite the important role they play in regulating Earth’s climate system. Marine mammals equipped with biologging devices are now being used to fill the data gaps in these logistically difficult to sample regions. Since 2002, instrumented animals have been generating exceptionally large data sets of oceanographic CTD casts (>500,000 profiles), which are now freely available to the scientific community through the MEOP data portal (http://meop.net). MEOP (Marine Mammals Exploring the Oceans Pole to Pole) is a consortium of international researchers dedicated to sharing animal-derived data and knowledge about the polar oceans. Collectively, MEOP demonstrates the power and cost-effectiveness of using marine mammals as data-collection platforms that can dramatically improve the ocean observing system for biological and physical oceanographers. Here, we review the MEOP program and database to bring it to the attention of the international community.http://www.tos.org/oceanographyam2017Mammal Research InstituteZoology and Entomolog

    Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

    Get PDF
    Background Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. Methods RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047. Findings Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths. Interpretation Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population

    Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

    Get PDF
    Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society

    Co-production of electricity and ethanol, process economics of value prior combustion

    Get PDF
    A process economic analysis of co-producing bioethanol and electricity (value prior to combustion) from mixed southern hardwood and southern yellow pine is presented. Bioethanol is produced by extracting carbohydrates from wood via autohydrolysis, membrane separation of byproducts, enzymatic hydrolysis of extracted oligomers and fermentation to ethanol. The residual solids after autohydrolysis are pressed and burned in a power boiler to generate steam and electricity. A base case scenario of biomass combustion to produce electricity is presented as a reference to understand the basics of bio-power generation economics. For the base case, minimum electricity revenue of 7070–96/MWh must be realized to achieve a 6–12% internal rate of return. In the alternative co-production cases, the ethanol facility is treated as a separate business entity that purchases power and steam from the biomass power plant. Minimum ethanol revenue required to achieve a 12% internal rate of return was estimated to be 0.840.84–1.05/l for hardwood and 0.740.74–0.85/l for softwood. Based on current market conditions and an assumed future ethanol selling price of $0.65/l, the co-production of cellulosic bioethanol and power does not produce financeable returns. A risk analysis indicates that there is a probability of 26.6% to achieve an internal rate of return equal or higher than 12%. It is suggested that focus be placed on improving yield and reducing CAPEX before this technology can be applied commercially. This modeling approach is a robust method to evaluate economic feasibility of integrated production of bio-power and other products based on extracted hemicellulose

    The NREL Biochemical and Thermochemical Ethanol Conversion Processes: Financial and Environmental Analysis Comparison

    No full text
    The financial and environmental performance of the National Renewable Energy Lab’s (NREL) thermochemical and biochemical biofuel conversion processes are examined herein with pine, eucalyptus, unmanaged hardwood, switchgrass, and sweet sorghum. The environmental impacts of the process scenarios were determined by quantifying greenhouse gas (GHG) emissions and TRACI impacts. Integrated financial and environmental performance metrics were introduced and used to examine the biofuel production scenarios. The thermochemical and biochemical conversion processes produced the highest financial performance and lowest environmental impacts when paired with pine and sweet sorghum, respectively. The high ash content of switchgrass and high lignin content of loblolly pine lowered conversion yields, resulting in the highest environmental impacts and lowest financial performance for the thermochemical and biochemical conversion processes, respectively. Biofuel produced using the thermochemical conversion process resulted in lower TRACI single score impacts and somewhat lower GHG emissions per megajoule (MJ) of fuel than using the biochemical conversion pathway. The cost of carbon mitigation resulting from biofuel production and corresponding government subsidies was determined to be higher than the expected market carbon price. In some scenarios, the cost of carbon mitigation was several times higher than the market carbon price, indicating that there may be other more cost-effective methods of reducing carbon emissions

    THERMO-MECHANICAL PULPING AS A PRETREATMENT FOR AGRICULTURAL BIOMASS FOR BIOCHEMICAL CONVERSION

    No full text
    The use of thermo-mechanical pulping (TMP), an existing and well known technology in the pulp and paper industry, is proposed as a potential pretreatment pathway of agriculture biomass for monomeric sugar production in preparation for further fermentation into alcohol species. Three agricultural biomass types, corn stover, wheat straw, and sweet sorghum bagasse, were pretreated in a TMP unit under two temperature conditions, 160 ºC and 170 ºC, and hydrolyzed using cellulase at 5, 10, and 20 FPU/g OD biomass. Wheat straw biomass was further pretreated at different conditions including: i) soaking with acetic acid, ii) longer steaming residence time (15 and 30 min), and iii) refined at lower disk gap (0.0508 and 0.1524 mm). Preliminary results showed that carbohydrate conversion increased from 25% to 40% when the TMP temperature was increased from 160 to 170 ºC. Carbohydrate conversion was relatively similar for the three biomasses under the same pretreatment conditions and enzyme loading. Acetic acid soaking and refining at a reduce disk gap increases carbohydrate conversion. Further studies within this technological field to identify optimum process and TMP conditions for pretreatment are suggested

    Economics, Environmental Impacts, and Supply Chain Analysis of Cellulosic Biomass for Biofuels in the Southern US: Pine, Eucalyptus, Unmanaged Hardwoods, Forest Residues, Switchgrass, and Sweet Sorghum

    No full text
    The production of six regionally important cellulosic biomass feedstocks, including pine, eucalyptus, unmanaged hardwoods, forest residues, switchgrass, and sweet sorghum, was analyzed using consistent life cycle methodologies and system boundaries to identify feedstocks with the lowest cost and environmental impacts. Supply chain analysis was performed for each feedstock, calculating costs and supply requirements for the production of 453,592 dry tonnes of biomass per year. Cradle-to-gate environmental impacts from these modeled supply systems were quantified for nine mid-point indicators using SimaPro 7.2 LCA software. Conversion of grassland to managed forest for bioenergy resulted in large reductions in GHG emissions due to carbon uptake associated with direct land use change. By contrast, converting forests to cropland resulted in large increases in GHG emissions. Production of forest-based feedstocks for biofuels resulted in lower delivered cost, lower greenhouse gas (GHG) emissions, and lower overall environmental impacts than the agricultural feedstocks studied. Forest residues had the lowest environmental impact and delivered cost per dry tonne. Using forest-based biomass feedstocks instead of agricultural feedstocks would result in lower cradle-to-gate environmental impacts and delivered biomass costs for biofuel production in the southern U.S

    Larch Biorefinery: Technical and Economic Evaluation

    No full text
    In this study a forest biorefinery concept based on larch wood was technically and economically evaluated. Two slightly different cases of a larch-based biorefinery were compared to conventional kraft pulping. The wood chips of Larix sibirica (Lebed.) were pre-extracted (PE) and washed with water prior to pulping, in order to generate an additional sugar side-stream. The sugars were hydrolyzed into monosugars, which were then fermented by Bacillus coagulans into lactic acid. The lactic acid needs to be purified before sold to the market. By pulping the pre-extracted wood chips with anthraquinone (AQ) and polysulfide (PS), the pulp yield loss was reduced. The pulp was then bleached (O-D0-Ep-D1-P). The products of this larch biorefinery are bleached softwood pulp and lactic acid. Three process cases were simulated: conventional kraft pulping, PE-PSAQ with 0.5% PS, and PE-PSAQ with 2% PS, in terms of mass and energy balances. Considering the availability of larch resources, this kind of a biorefinery could suitably be located in Siberia, Russia. Market prices were collected, and based on the simulation results, cash flows were determined. Sensitivity analysis was carried out, and investment costs were estimated. Based on the simulation with the addition of a lactic acid production line to an existing pulp mill, the payback time for the investment costs would be about 16 months
    corecore